Skip to content
Review Open access

p38γ and p38δ MAP kinases in inflammation

Oct 2026 · Biochemical Society Transactions · Vol 54, pp. 1451 - 1461 · 0 citations · 63 references
Medicine

TL;DR

Current knowledge of the molecular features, substrates, immune cell functions, and disease associations of p38γ and p38δ is summarized and their potential as therapeutic targets while addressing the challenges associated with their pharmacological modulation is discussed.

Abstract

Abstract The p38γ and p38δ mitogen-activated protein kinases (MAPKs) are members of the p38 family that have emerged as important regulators of inflammatory signaling. Initially considered minor or alternative isoforms, accumulating evidence has revealed distinct and overlapping functions for p38γ and p38δ in innate immunity, tissue homeostasis, inflammatory disease, and cancer. These kinases regulate immune responses through diverse mechanisms controlling cytokine production, gene expression, immune-cell activation, and migration. In addition, recent studies suggest that some functions of p38γ and p38δ may occur independently of their catalytic activity, highlighting the complexity of their biological roles. The present review summarizes current knowledge of the molecular features, substrates, immune cell functions, and disease associations of p38γ and p38δ and discusses their potential as therapeutic targets while addressing the challenges associated with their pharmacological modulation.

Read PDF

Similar papers

Review Aug 2026

Atypical p38 kinase signaling and pathological impact on human health.

Protein phosphorylation is a fundamental mechanism regulating signal transduction, metabolic control, and cellular adaptation to environmental stress, with these processes orchestrated largely by protein kinases organized into hierarchical signaling cascades. Among these, the p38 mitogen-activated protein kinases (MAPK...

Fredejah T. Royer, Lillian Schulz, Abby E. Young et al. · 0 citations
Review Oct 2026

RIPK1 kinase and scaffold activities in tumor cell fate and therapy.

Receptor-interacting protein kinase 1 (RIPK1) plays a pivotal role in regulating cell survival and death, thereby exerting complex and multifaceted functions in the initiation and progression of cancer. Its expression is frequently dysregulated across diverse malignancies and correlates strongly with poor prognosis, hi...

Jing-Yu Luo, Shu-Ya Song, Ze-Kun Li et al. · 0 citations
Review Open access Sep 2026

Targeting MAPK9 in neurodegenerative diseases: mechanistic insights, phytochemical modulators, and emerging computational approaches

The protein Mitogen-activated protein kinase 9 (MAPK9) (c-Jun N-terminal kinase 2 [JNK2]) is a critical signalling molecule involved in cellular survival, inflammation, oxidative stress, and the programming of cell death. This is because there has been emerging evidence of the effects of the abnormal activation of MAPK...

S. Otun, I. Achilonu · 0 citations
Review Open access Sep 2026

The role of mTORC2/RICTOR in immune cells and inflammatory diseases

mTORC2, defined by its core component RICTOR, is a key regulator of immune cell function and inflammation, yet its roles have long been underappreciated due to lack of specific inhibitors and in vivo tools. This review summarizes the current understanding of mTORC2-specific signaling (via AKT, SGK1, and PKC) in regulat...

Jing-Ting Xu, Wen-Xing Zhong, Fei Xin et al. · 0 citations
Review Sep 2026

Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential.

The biology of IL-33 and its receptor, ST2, and the functional relevance of IL-33-ST2 signalling are discussed, particularly on the differential regulation of IL-33 sensitivity in distinct cell types in diverse tissue settings.

S. Serve, M. Löhning · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.